Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoserine phosphatase pseudogene 1 (PSPHP1) is a human pseudogene located on chromosome 7 that is highly homologous to the functional phosphoserine phosphatase gene but lacks protein-coding function due to inactivating mutations or genomic context[2][3][8]. PSPHP1 is significantly upregulated in fibroblasts from Fanconi's anemia patients, particularly in B-cells of complementation group A, while its expression is low or absent in normal fibroblasts[2][5][8]. Despite this distinctive expression pattern, there is no evidence that PSPHP1 encodes a functional protein or acts as a therapeutic target; instead, it may play a role in regulating gene expression at the RNA level in certain disease contexts[2][6][7]. No small molecules or biologics specifically target PSPHP1, and it is not implicated in classic pathways of signal transduction, transport, or catalysis[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoserine phosphatase pseudogene 1 (PSPHP1).